ZnT-9 Antibodies

Santa Cruz Biotechnology offers a broad range of ZnT-9 monoclonal antibodies for research focused on understanding zinc transporter protein ZnT-9. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZnT-9 maintains cellular zinc homeostasis and plays a significant role in cellular signaling and metabolism. Research has shown that ZnT-9 dysregulation is linked to various diseases, including neurodegenerative disorders and cancer, highlighting its importance as a therapeutic research target. Investigating ZnT-9 function provides valuable insights into zinc transport mechanisms and their impact on cellular health. Researchers worldwide utilize ZnT-9 monoclonal antibodies to advance understanding of zinc transport pathways and their roles in disease development. Current studies of ZnT-9 continue to reveal new aspects of cellular zinc regulation and its broader implications for human health. Santa Cruz Biotechnology monoclonal antibodies for ZnT-9 enable researchers to make meaningful contributions to the scientific understanding of zinc transport mechanisms and their therapeutic applications.